Molecule Information
General Information of the Molecule (ID: Mol01014)
Name |
Multidrug resistance protein 1 (ABCB1)
,Sus scrofa
|
||||
---|---|---|---|---|---|
Synonyms |
ABCB1; Fragment
Click to Show/Hide
|
||||
Molecule Type |
Protein
|
||||
Gene Name |
ABCB1
|
||||
Sequence |
GQKKELERYNKNLEEAKRIGIKKAITANISIGAAFLLIYASYALAFWYGTTLVLSNEYTI
GQVLTVFFSVLIGAFSVGQASPSIEAFANARGAAYEIFKIIDSKPSIDSYSKNGHKPDNI KGNLEFRNVHFSYPSRNEVKILKGLNLKVESGQTVALVGNSGCGKSTTVQLMQRLYDPTE GVVSIDGQDIRTINVRYLREIIGVVSQEPVLFATTIAENIRYGRENVTMEEIEKAVKEAN AYDFIMKLPNKFDTLVGERGAQLSGGQKQRIAIARALVRNPKILLLDEATSALDTESEAV VQVALDKAREGRTTIVIAHRLSTVRNADVIAGFDDGVIVEKGSHDELMKEKGVYFKLVTM QTKGNEIELENTVGVSKGVVDALDMSPKDLESSLIRRGSTRKSIKGPQGQDRKLSTKEGL DENVPPVSFWRILKLNITEWPYFVVGIFCAIINGGLQPAFSIIFSRIIGVFTKVTDPETK RQDSNIFSLLFLILGIISFITFFLQGFTFGKAGEILTKRLRYMVFRSMLRQDVSWFDDPK NTTGALTTRLANDAAQVKGAIGSRLAVITQNIANLGTGIIISFIYGWQLTLLLLAIVPII AIAGVVEMKMLSGQALKDKKELEGAGKIATEAIENFRTVVSLTREEKFESMYDQSLQVPY SNSLRKAHIFGITFSITQAMMYFSYAACFRFGAYLVQHGHMDFQDVLLVFSAIVFGAMAV GQVSSFAPDYAKAKVSASHVIMIIEKTPQIDSYSTVGLKPNTVEGNLTFNEVMFNYPTRP DIPVLQGLSLEVKKGQTLALVGSSGCGKSTVVQLLERFYDPLAGKVLIDGREIKELNVQW LRAHMGIVSQEPILFDCSIAENIAYGDNSRVVSQEEIVQAAKEANIHPFIETLPDKYNTR VGDKGTQLSGGQKQRIAIARALVRRPRILLLDEATSALDTESEKVVQEALDKAR Click to Show/Hide
|
||||
Uniprot ID | |||||
Click to Show/Hide the Complete Species Lineage | |||||
Type(s) of Resistant Mechanism of This Molecule
IDUE: Irregularity in Drug Uptake and Drug Efflux
Drug Resistance Data Categorized by Drug
Approved Drug(s)
3 drug(s) in total
Chlorpromazine
Drug Sensitivity Data Categorized by Their Corresponding Mechanisms | ||||
Irregularity in Drug Uptake and Drug Efflux (IDUE) | ||||
Disease Class: Psychosis | [1] | |||
Sensitive Disease | Psychosis [ICD-11: 6D8Z.0] | |||
Sensitive Drug | Chlorpromazine | |||
Molecule Alteration | Expression | Down-regulation |
||
Experimental Note | Revealed Based on the Cell Line Data | |||
In Vitro Model | L-MDR1 cells(Sus scrofa (Pig)) | Kidney | Homo sapiens (Human) | CVCL_0391 |
LLC-Pk1 cells(Sus scrofa (Pig)) | Kidney | Homo sapiens (Human) | CVCL_0391 | |
Experiment for Drug Resistance |
Flow cytometric assay | |||
Mechanism Description | The multidrug resistance transporter, P-glycoprotein (P-gp), is involved in efflux transport of several antipsychotics in the blood-brain barrier (BBB). All the antipsychotics showed various degrees of inhibitory effects on P-gp activity at concentrations ranging from 1 to 100 uM. However, risperidone and olanzapine are the most likely agents that may inhibit P-gp activity. |
Clozapine
Drug Sensitivity Data Categorized by Their Corresponding Mechanisms | ||||
Irregularity in Drug Uptake and Drug Efflux (IDUE) | ||||
Disease Class: Psychosis | [1] | |||
Sensitive Disease | Psychosis [ICD-11: 6D8Z.0] | |||
Sensitive Drug | Clozapine | |||
Molecule Alteration | Expression | Down-regulation |
||
Experimental Note | Revealed Based on the Cell Line Data | |||
In Vitro Model | L-MDR1 cells(Sus scrofa (Pig)) | Kidney | Homo sapiens (Human) | CVCL_0391 |
LLC-Pk1 cells(Sus scrofa (Pig)) | Kidney | Homo sapiens (Human) | CVCL_0391 | |
Experiment for Drug Resistance |
Flow cytometric assay | |||
Mechanism Description | The multidrug resistance transporter, P-glycoprotein (P-gp), is involved in efflux transport of several antipsychotics in the blood-brain barrier (BBB). All the antipsychotics showed various degrees of inhibitory effects on P-gp activity at concentrations ranging from 1 to 100 uM. However, risperidone and olanzapine are the most likely agents that may inhibit P-gp activity. |
Haloperidol
Drug Sensitivity Data Categorized by Their Corresponding Mechanisms | ||||
Irregularity in Drug Uptake and Drug Efflux (IDUE) | ||||
Disease Class: Psychosis | [1] | |||
Sensitive Disease | Psychosis [ICD-11: 6D8Z.0] | |||
Sensitive Drug | Haloperidol | |||
Molecule Alteration | Expression | Down-regulation |
||
Experimental Note | Revealed Based on the Cell Line Data | |||
In Vitro Model | L-MDR1 cells(Sus scrofa (Pig)) | Kidney | Homo sapiens (Human) | CVCL_0391 |
LLC-Pk1 cells(Sus scrofa (Pig)) | Kidney | Homo sapiens (Human) | CVCL_0391 | |
Experiment for Drug Resistance |
Flow cytometric assay | |||
Mechanism Description | The multidrug resistance transporter, P-glycoprotein (P-gp), is involved in efflux transport of several antipsychotics in the blood-brain barrier (BBB). All the antipsychotics showed various degrees of inhibitory effects on P-gp activity at concentrations ranging from 1 to 100 uM. However, risperidone and olanzapine are the most likely agents that may inhibit P-gp activity. |
References
If you find any error in data or bug in web service, please kindly report it to Dr. Sun and Dr. Zhang.